Patent pools and diagnostic testing

Trends in Biotechnology

Volumn 24, Issue 3, 2006, Pages 115-120

  Verbeure, Birgit ^a   Van Zimmeren, Esther ^a   Matthijs, Gert ^a   Van Overwalle, Geertrui ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; DIAGNOSIS; ELECTRONICS INDUSTRY; GENETIC ENGINEERING; TELECOMMUNICATION INDUSTRY; VIRUSES;

DIAGNOSTIC TESTING; SARS GENOME;

PATENTS AND INVENTIONS;

BREAST CANCER; COLORECTAL CANCER; DIAGNOSTIC TEST; ELECTRONICS; GENE MUTATION; GENETIC SCREENING; GENOME; HUMAN; NEUROFIBROMATOSIS; OVARY CANCER; PATENT; PRIORITY JOURNAL; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; TELECOMMUNICATION; TUBEROUS SCLEROSIS;

ANIMALS; GENETICS; GENOME, VIRAL; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PATENTS; SARS VIRUS;

EID: 33644518190     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2006.01.002     Document Type: Review

References (37)

1. Shapiro, C. (2001) Navigating the patent thicket: cross licenses, patent pools and standard setting. In Innovation Policy and the Economy (Vol. I) (Jaffe, E. et al., eds), pp. 119-150, MIT Press (Also available at http://haas.berkeley.edu/∼shapiro/thicket.pdf )
2. F.M. Scherer The economics of human gene patents Acad. Med. 77 2002 1348 1367
3. Straus, J. et al. (2002) Genetic inventions and patent law, Max-Planck-Institüt für ausländisches und internationals Patent-, Urheber- und Wettbewerbsrecht & Bundesminsterium für Bilding und Forschung
4. Walsh, J. et al. (2003) Effects of research tool patents and licensing on biomedical innovation. In Patents in the Knowledge-Based Economy. (Cohen, W.M. and Merrill, S.A., eds), pp. 285-240, National Academic Press
5. J.F. Merz Diagnostic testing fails the test Nature 415 2002 577 579
6. Nicol, D. and Nielsen, J. (2003) Patents and Medical Biotechnology: an Empirical Analysis of Issues Facing the Australian Industry, Centre for Law and Genetics, Occasional paper 6 (also available at http://www.law.unimelb.edu.au/ ipria/publications/reports.html)
7. M.A. Heller, and R.S. Eisenberg Can patents deter innovation? The anticommons in biomedical research Science 280 1998 698 701
8. M. Heller The tragedy of the anticommons: property in the transition from Marx to markets Harv. Law Rev. 111 1998 621 688
9. Van Overwalle, G. et al. (2005) Models for facilitating access to patents on genetic inventions. Nat. Rev. Gen. DOI:10.1038/nrg1765 (http://www.nature. com/nrg/index.html )
10. Clark, J. (2000) Patent pools: a solution to the problem of access in biotechnology patents? White Paper commissioned by Q. Todd Dickinson, the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (available at http://www.uspto.gov/web/ offices/pac/dapp/opla/patentpool.pdf )
11. R. Merges Institutions for intellectual property transactions: the case of patent pools R. Dreyfuss Expanding the Boundaries of Intellectual Property 2001 Oxford University Press 123 166
12. S.C. Carlson Patent pools and the antitrust dilemma Yale J. Regul. 16 1999 359 399
13. H.T. Dykman Patent licensing within the manufacturer's aircraft association Journal of the Patent Office Society 46 1964 646
14. US Department of Justice & Federal Trade Commission (1995) Antitrust Guidelines for the Licensing of Intellectual Property. ("IP Licensing Guidelines"), available at http://www.usDoJ.gov/atr/public/guidelines/ ipguide.htm )
15. European Commission (2004) Regulation (EC) No. 772/2004 of 27 April 2004 on the application of Article 81 (3) of the Treaty to categories of technology transfer agreements [2004] O.J. L 123/11.
16. This Regulation replaces Commission Regulation (EC) No. 240/96 of 31 January 1996 on the application of Article 85 (3) of the Treaty to certain categories of technology transfer agreements, [1996] O.J. L 31/2
17. European Commission (2004) Guidelines on the application of Article 81 of the EC Treaty to technology transfer agreements [2004] O.J. C 101/2
18. Japanese Fair Trade Commission (2005) Guidelines on Standardization and Patent Pool Arrangements (available at http://www.jftc.go.jp/e-page/legislation/ ama/patentpool.pdf)
19. J.A. Goldstein Patent pools as a solution to the licensing problems of diagnostic genetics, United States and European perspectives Drug Discovery World 2005 86 91
20. S.C. Carlson Patent pools and the antitrust dilemma Yale Journal on Regulation 16 1999 359 399
21. Organization for Economic Co-Operation and Development (OECD) (2002) Genetic Inventions, Intellectual Property Rights and Licensing Practices, Report of a workshop organized by the OECD Working Party on Biotechnology (available at http://www.oecd.org/dataoecd/42/21/2491084.pdf)
22. T.J. Eversible Patent pools as a solution to the licensing problems of diagnostic genetics Intellectual Property & Technology Law Journal 17 2005 6 13
23. T.J. Eversible Patent pools and standard setting in diagnostic genetics Nat. Biotechnol. 23 2005 937 938
24. P. Beyer Golden Rice: introducing the beta-carotene biosynthesis pathway into rice endosperm by genetic engineering to defeat vitamin A deficiency J. Nut. 132 2002 506S 510S
25. Ryder, R.D. et al. (2000) The intellectual and technical property components of pro-vitamin A rice (Golden Rice™): a preliminary freedom to operate review. In ISAAA Briefs No. 20, ISAAA: Ithaca (also available at www.isaaa.org )
26. Lubbock, A.C. (2003) Public goods and public policy for agricultural biotechnology. 7th ICABR International Conference, Ravalli (Italy), June 29 to July 3
27. Graff, G. and Silverman, D. (2001) Towards an intellectual property clearing house for Ag-biotechnology. An Issues Paper. IP Strategy Today Volume 3 (available at www.bioDevelopments.org)
28. Graff, G. et al. (2001) Towards an intellectual property clearing house for Ag-biotechnology. Summary of an Industry, Academia and International Development Round Table. IP Strategy Today Volume 3 (available at www.bioDevelopments.org )
29. G.D. Graff The public-private structure of intellectual property ownership in agricultural biotechnology Nat. Biotechnol. 21 2003 989 995
30. R. Parish, and R. Jargons Using the industry model to create physical science patent pools among academic institutions Journal of the Association of University Technology Managers 2003 65 79
31. J. Simon Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling Bulletin of the World Health Organization 83 2005 707 710
32. P.A. Rota Characterization of a novel corona virus associated with severe acute respiratory syndrome Science 300 2003 1394 1399
33. M.A. Marra The genome sequence of the SARS-associated coronavirus. Characterization of a novel Corona virus associated with severe acute respiratory syndrome Science 300 2003 1399 1404
34. European Commission (1992) Communication of 27 October 1992 on Intellectual Property Rights and Standardization, COM (92) 445 final
35. C.S. Richards Standards and guidelines for CFTR mutation testing Genet. Med. 4 2002 379 391
36. N.T. Potter Technical standards and guidelines for Huntington's disease testing Genet. Med. 6 2004 61 65
37. J.F. Mars Diagnostic testing fails the test Nature 415 2002 577 579